Olema Pharmaceuticals Inc (OLMA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $662.30M
Last updated: Nov 17, 2026 at 11:06 AM ET
Olema Pharmaceuticals Inc (OLMA) Earnings: Report Dates and Results
Olema Pharmaceuticals (OLMA) is expected to report earnings on Mar 15, 2027. In the quarter ended Sep 30, 2026, Olema Pharmaceuticals reported EPS of -$0.73, below the -$0.60 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
OLMA has an expected report date of Mar 15, 2027.
Earnings History
Of the 25 quarters below that had an estimate, OLMA beat 8, missed 15 and matched 2. The widest gap in the table came in the quarter ended Dec 31, 2024, when EPS landed 394.46% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.73 | -$0.60 | -$0.73 - -$0.50 | -21.67% | Miss | N/A | 9 | 1 up, 7 down | Nov 9, 2026 |
| Jun 30, 2026 | -$0.61 | -$0.53 | -$0.63 - -$0.49 | -15.09% | Miss | N/A | 9 | 4 up, 4 down | Aug 10, 2026 |
| Mar 31, 2026 | -$0.52 | -$0.54 | -$0.59 - -$0.50 | +3.70% | Beat | N/A | 10 | 3 up, 2 down | May 12, 2026 |
| Dec 31, 2025 | -$0.50 | -$0.52 | -$0.65 - -$0.44 | +3.28% | Beat | N/A | 9 | 0 up, 1 down | Mar 16, 2026 |
| Sep 30, 2025 | -$0.49 | -$0.45 | -$0.58 - -$0.38 | -8.89% | Miss | N/A | 8 | 5 up, 0 down | Nov 10, 2025 |
| Jun 30, 2025 | -$0.51 | -$0.44 | -$0.70 - -$0.37 | -15.91% | Miss | N/A | 6 | 1 up, 0 down | Aug 11, 2025 |
| Mar 31, 2025 | -$0.36 | -$0.46 | -$0.59 - -$0.39 | +21.74% | Beat | N/A | 3 | 2 up, 0 down | May 13, 2025 |
| Dec 31, 2024 | -$0.51 | $0.17 | -$0.70 - $4.23 | -394.46% | Miss | N/A | 6 | 3 up, 3 down | Mar 18, 2025 |
| Sep 30, 2024 | -$0.60 | -$0.57 | -$0.63 - -$0.50 | -5.26% | Miss | N/A | 7 | 0 up, 0 down | Nov 12, 2024 |
| Jun 30, 2024 | -$0.54 | -$0.54 | -$0.65 - -$0.47 | 0.00% | In line | N/A | 7 | 0 up, 0 down | Aug 6, 2024 |
| Mar 31, 2024 | -$0.56 | -$0.55 | -$0.58 - -$0.51 | -1.82% | Miss | N/A | 7 | 0 up, 0 down | May 8, 2024 |
| Dec 31, 2023 | -$0.49 | -$0.48 | -$0.65 - -$0.40 | -2.08% | Miss | N/A | 9 | 0 up, 0 down | Mar 11, 2024 |
| Sep 30, 2023 | -$0.48 | -$0.51 | -$0.69 - -$0.38 | +5.88% | Beat | N/A | 8 | 0 up, 0 down | Nov 7, 2023 |
| Jun 30, 2023 | -$0.49 | -$0.71 | -$0.75 - -$0.69 | +30.99% | Beat | N/A | 7 | 0 up, 0 down | Aug 8, 2023 |
| Mar 31, 2023 | -$0.70 | -$0.69 | -$0.73 - -$0.60 | -1.45% | Miss | N/A | 6 | 0 up, 0 down | May 9, 2023 |
| Dec 31, 2022 | -$0.65 | -$0.65 | -$0.75 - -$0.59 | 0.00% | In line | N/A | 5 | 0 up, 0 down | Mar 9, 2023 |
| Sep 30, 2022 | -$0.57 | -$0.78 | -$0.90 - -$0.68 | +26.92% | Beat | N/A | 5 | 0 up, 0 down | Nov 8, 2022 |
| Jun 30, 2022 | -$0.82 | -$0.66 | N/A | -24.24% | Miss | N/A | N/A | 0 up, 0 down | Aug 9, 2022 |
| Mar 31, 2022 | -$0.58 | -$0.60 | -$0.64 - -$0.45 | +3.33% | Beat | N/A | 4 | 0 up, 0 down | May 9, 2022 |
| Dec 31, 2021 | -$0.54 | -$0.49 | -$0.65 - -$0.45 | -10.20% | Miss | N/A | 5 | 0 up, 0 down | Feb 28, 2022 |
| Sep 30, 2021 | -$0.45 | -$0.43 | -$0.51 - -$0.42 | -4.65% | Miss | N/A | 5 | N/A | Nov 10, 2021 |
| Jun 30, 2021 | -$0.42 | -$0.38 | -$0.42 - -$0.33 | -10.53% | Miss | N/A | 5 | N/A | Aug 10, 2021 |
| Mar 31, 2021 | -$0.39 | -$0.27 | -$0.29 - -$0.27 | -44.44% | Miss | N/A | 4 | N/A | May 11, 2021 |
| Dec 31, 2020 | -$0.50 | -$0.18 | -$0.24 - -$0.10 | -177.78% | Miss | N/A | 3 | N/A | Mar 17, 2021 |
| Sep 30, 2020 | -$0.03 | -$0.50 | N/A | +94.00% | Beat | N/A | N/A | N/A | Nov 19, 2020 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.86, after -$2.21 the year before. It was -$0.53 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.86 | N/A |
| Dec 31, 2024 | -$2.21 | N/A |
| Dec 31, 2023 | -$2.16 | N/A |
| Dec 31, 2022 | -$2.62 | N/A |
| Dec 31, 2021 | -$1.80 | N/A |
| Dec 31, 2020 | -$0.53 | N/A |
Frequently Asked Questions About OLMA
When is Olema Pharmaceuticals's next earnings date?
Olema Pharmaceuticals's next earnings report is expected for Mar 15, 2027.
Did OLMA beat earnings estimates last quarter?
No. Olema Pharmaceuticals reported EPS of -$0.73 for the quarter ended Sep 30, 2026, below the -$0.60 estimate by 21.67%.
What EPS do analysts expect from OLMA next quarter?
The consensus EPS estimate for Olema Pharmaceuticals for the quarter ending Dec 31, 2026 is -$0.72 from 12 analysts, with estimates from -$0.76 to -$0.55.
How often does OLMA beat earnings estimates?
Olema Pharmaceuticals beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -53.41%.
OLMA pages: Overview, Earnings, Forecast, Financials, Competitors